Champions Oncology Inc. (CSBR)
NASDAQ: CSBR
· Real-Time Price · USD
6.53
0.01 (0.15%)
At close: Aug 15, 2025, 3:59 PM
6.52
-0.15%
After-hours: Aug 15, 2025, 04:00 PM EDT
Champions Oncology Income Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Revenue | 44.59M | 58.59M | 53.57M | 51.65M | 50.15M | 49.22M | 49.98M | 52.69M | 53.87M | 53.68M | 54.1M | 51.6M | 49.11M | 46.8M | 44.42M | 42.75M | 41.04M | 39.23M | 37.43M | 34.93M |
Cost of Revenue | 28.03M | 28.01M | 29.24M | 28.79M | 29.4M | 29.49M | 29.34M | 30.16M | 29.53M | 28.41M | 27.12M | 25.29M | 23.63M | 23.06M | 21.5M | 21.54M | 21.48M | 20.75M | 20.23M | 18.46M |
Gross Profit | 16.56M | 30.58M | 24.33M | 22.86M | 20.75M | 19.74M | 20.64M | 22.52M | 24.34M | 25.26M | 26.97M | 26.31M | 25.48M | 23.73M | 22.92M | 21.21M | 19.57M | 18.48M | 17.2M | 16.47M |
Operating Income | 4.55M | 6.72M | -352K | -3.04M | -6.92M | -8.8M | -8.68M | -6.72M | -4.45M | -3.05M | 242K | 498K | 607K | 462K | 395K | 139K | 338K | -1.12M | -1.45M | -1.16M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 4.63M | 6.4M | -637K | -3.44M | -7.31M | -9.66M | -9.56M | -7.5M | -5.27M | -3.07M | 148K | 439K | 583K | 480K | 437K | 164K | 410K | -1.09M | -1.43M | -1.13M |
Net Income | 4.7M | 6.43M | -598K | -3.4M | -7.28M | -9.73M | -9.64M | -7.58M | -5.33M | -3.12M | 108K | 401K | 548K | 411K | 364K | 88K | 335K | -1.23M | -1.56M | -1.26M |
Selling & General & Admin | 16.88M | 16.59M | 16.95M | 17.7M | 18.13M | 18.19M | 17.96M | 17.79M | 17.24M | 17.02M | 16.47M | 15.86M | 15.5M | 14.42M | 13.97M | 13.17M | 12.03M | 12.32M | 11.85M | 11.15M |
Research & Development | 6.83M | 6.91M | 7.38M | 8.2M | 9.54M | 10.35M | 11.36M | 11.45M | 11.55M | 11.28M | 10.26M | 9.96M | 9.37M | 8.85M | 8.55M | 7.9M | 7.2M | 6.95M | 6.46M | 6.15M |
Other Expenses | n/a | n/a | 58K | 58K | 72K | 52K | -6K | -15K | -47K | -62K | -94K | -59K | -24K | 18K | 42K | 25K | 8K | -43K | -49K | -31K |
Operating Expenses | 23.71M | 23.5M | 24.32M | 25.9M | 27.67M | 28.53M | 29.32M | 29.24M | 28.79M | 28.31M | 26.73M | 25.82M | 24.87M | 23.27M | 22.52M | 21.07M | 19.23M | 19.26M | 18.31M | 17.3M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 584K | 584K | 593K | 611K | 27K | 59K | 50K | 32K | 32K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 7.54M | 7.01M | 7M | 7.05M | 7.06M | 7.14M | 7.1M | 7.01M | 7M | 6.77M | 6.56M | 6.5M | 6.38M | 6.24M | 6.18M | 5.89M | 5.52M | 5.14M | 4.95M | 4.58M |
Cost & Expenses | 51.74M | 51.51M | 53.57M | 54.69M | 57.07M | 58.02M | 58.66M | 59.4M | 58.32M | 56.72M | 53.85M | 51.1M | 48.5M | 46.34M | 44.02M | 42.61M | 40.7M | 40.01M | 38.54M | 35.76M |
Income Tax Expense | -75K | -27K | -39K | -39K | -32K | 70K | 76K | 79K | 68K | 46K | 40K | 38K | 35K | 69K | 73K | 76K | 75K | 136K | 133K | 129K |
Shares Outstanding (Basic) | 13.75M | 13.7M | 13.59M | 13.59M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.55M | 13.53M | 13.52M | 13.28M | 13.5M | 13.43M | 13.4M | 13.4M | 13.37M | 13.06M | 12.73M |
Shares Outstanding (Diluted) | 13.75M | 14.36M | 14.02M | 14.04M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.56M | 13.53M | 13.52M | 13.51M | 14.39M | 14.55M | 13.4M | 13.4M | 14.51M | 15.06M | 14.23M |
EPS (Basic) | 0.35 | 0.47 | -0.05 | -0.25 | -0.54 | -0.72 | -0.71 | -0.56 | -0.39 | -0.23 | 0.01 | 0.03 | 0.04 | 0.03 | 0.04 | 0.02 | 0.04 | -0.09 | -0.13 | -0.1 |
EPS (Diluted) | 0.33 | 0.45 | -0.05 | -0.25 | -0.54 | -0.72 | -0.71 | -0.56 | -0.39 | -0.23 | -0.00 | 0.02 | 0.03 | 0.02 | 0.04 | 0.02 | 0.04 | -0.09 | -0.13 | -0.11 |
EBITDA | 5.82M | 8.45M | 1.43M | -1.17M | -5.05M | -6.8M | -6.59M | -5.11M | -2.76M | -1.38M | 1.34M | 1.94M | 1.84M | 1.61M | 2.06M | 1.76M | 1.92M | 445K | -182K | -27K |
EBIT | 6.56M | 6.37M | -707K | -3.39M | -7.28M | -8.8M | -8.68M | -6.73M | -4.46M | -3.06M | 201K | 492K | 601K | 463K | 420K | 147K | 410K | -718K | -1.05M | -752K |
Depreciation & Amortization | 1.25M | 1.7M | 2.57M | 2.65M | 2.65M | 2.91M | 2.22M | 2.57M | 2.92M | 3.02M | 2.86M | 2.65M | 2.41M | 2.07M | 1.95M | 1.64M | 1.36M | 1.13M | 1.05M | 920K |